Skip to main content

Table 1 Baseline characteristics of the study patients according to the clusters (from HCPC)

From: Machine learning in a real-world PFO study: analysis of data from multi-centers in China

 

Total (n = 196)

Cluster 1 (n = 77)

Cluster 2 (n = 119)

P value

Age, years

42.70(12.37)

43.42(11.45)

42.24(12.95)

0.52

Gender, male

127(64.80%)

12(15.58%)

115(96.64%)

 < 0.001

Han destiny

179(91.79%)

69(90.79%)

110(92.44%)

0.68

Heart rate, bpm

77.30(11.46)

78.60(12.24)

76.45(10.83)

0.20

Systolic BP, mmHg

121.83(15.64)

117.27(16.63)

124.78(14.28)

 < 0.001

Diastolic BP, mmHg

76.74(10.78)

73.49(9.94)

78.85(10.78)

 < 0.001

Body mass index, kg/m2

23.37(3.25)

22.25(2.91)

24.12(3.26)

 < 0.001

History of stroke

120(61.22%)

44(57.14%)

76(63.87%)

0.35

History of TIA

84(42.86%)

36(46.75%)

48(40.34%)

0.38

History of migraine

27(13.78%)

14(18.18%)

13(10.92%)

0.15

Laboratory data

Red blood cell, 10*12/L

4.58(0.68)

4.16(0.52)

4.86(0.63)

 < 0.001

Hemoglobin, g/dl

132.92(18.96)

116.57(15.09)

143.50(12.66)

 < 0.001

HCT, L/L

40.16(5.09)

35.96(4.21)

42.88(3.52)

 < 0.001

APTT, s

35.02(5.70)

34.73(6.24)

35.22(5.32)

0.56

PT, s

13.21(2.82)

13.18(2.97)

13.22(2.73)

0.91

PTA%, %

71.80(42.27)

65.47(43.75)

76.21(40.85)

0.11

Fibrin, mg/dl

3.11(2.06)

3.25(2.36)

3.02(1.82)

0.44

AST, U/L

23.12(10.33)

20.58(9.58)

24.75(10.52)

0.006

ALT, U/L

27.90(22.14)

19.06(13.06)

33.67(24.84)

 < 0.001

Albumin, g/dl

40.77(4.70)

39.91(5.90)

41.31(3.69)

0.04

Creatinine, umol/L

69.62(15.39)

58.81(9.91)

76.58(14.24)

 < 0.001

BUN, mmol/L

4.95(2.73)

5.16(4.10)

4.81(1.20)

0.37

Uric acid, umol/L

363.32(96.93)

289.75(64.70)

408.80(84.97)

 < 0.001

Fasting blood glucose, mg/dL

5.04(1.25)

5.03(1.18)

5.05(1.30)

0.94

Triglycerides, mg/dL

1.39(0.88)

1.29(1.02)

1.45(0.77)

0.26

Total cholesterol, mg/dL

4.09(1.13)

4.27(1.20)

3.98(1.08)

0.11

LDL-C, mg/dL

2.38(0.84)

2.39(0.83)

2.38(0.85)

 > 0.99

HDL-C, mg/dL

1.21(0.56)

1.46(0.77)

1.05(0.26)

 < 0.001

Echocardiographic data

Presence of atrial septal aneurysm

17(9.66%)

2(2.99%)

15(13.76%)

0.02

LA, mm

32.15(4.08)

30.77(3.73)

33.03(4.06)

 < 0.001

LVEDD, mm

45.52(3.65)

43.79(3.40)

46.62(3.38)

 < 0.001

LVESD, mm

29.47(4.08)

28.97(4.22)

29.81(3.97)

0.18

IVS, mm

9.44(1.51)

8.67(1.21)

9.94(1.48)

 < 0.001

PW, mm

9.23(1.25)

8.60(1.13)

9.63(1.16)

 < 0.001

LVEF, %

65.87(5.49)

65.90(5.31)

65.87(5.49)

0.97

MVE/MVA

1.12(0.34)

1.13(0.35)

1.12(0.34)

0.83

RVEDD, mm

29.28(10.53)

29.36(10.23)

29.22(10.77)

0.94

  1. p value < 0.05 are shown in bold
  2. HCPC Hierarchical Clustering on Principal Components; TIA transient ischemic attack; AST Aspartate aminotransferase; ALT Alanine aminotransferase; LDL-C low-density lipoprotein cholesterol; HDL-C high-density lipoprotein cholesterol; LA left atrium; LVEDD left ventricular end-diastolic dimension; LVESD left ventricular end-systolic dimension; IVS interventricular septum; PW posterior wall; LVEF left ventricular ejection fraction; RVEDD right ventricular end-diastolic dimension